A Arava, Leflunomide CEP of the European Pharmacopoeia monograph is often referred to as a Arava, Leflunomide Certificate of Suitability (COS). The purpose of a Arava, Leflunomide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Arava, Leflunomide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Arava, Leflunomide to their clients by showing that a Arava, Leflunomide CEP has been issued for it. The manufacturer submits a Arava, Leflunomide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Arava, Leflunomide CEP holder for the record. Additionally, the data presented in the Arava, Leflunomide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Arava, Leflunomide DMF.
A Arava, Leflunomide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Arava, Leflunomide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Arava, Leflunomide suppliers with CEP (COS) on PharmaCompass.